Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Hepatitis B
All age groups
Older adults
Western Pacific
Clear all
Type of publications
NITAG documentation
(1)
Systematic reviews (SYSVAC)
(25)
Topics
Available to download in languages
Regions
Western Pacific
(26)
Africa
(20)
Americas
(14)
Eastern Mediterranean
(7)
Europe
(21)
South-East Asia
(3)
Countries
Australia
(2)
China
(24)
Diseases
COVID-19
(22)
Hepatitis B
(4)
Haemophilus influenzae type B
(1)
Hepatitis A
(1)
Herpes zoster
(1)
Human papillomavirus (HPV)
(4)
Influenza
(4)
Mumps
(1)
Pertussis
(2)
Pneumococcal disease
(5)
Poliomyelitis
(1)
Rabies
(1)
Rotavirus
(1)
Varicella
(1)
Vaccine topics
Acceptance
(1)
Administration
(1)
Coverage
(1)
Economic aspects
(1)
Efficacy/effectiveness
(4)
Ethical issues
(1)
Target population
All age groups
(17)
Older adults
(9)
Adolescents
(4)
Adults
(14)
Children
(4)
Healthcare workers
(3)
Newborn
(1)
Parents/caregivers
(3)
Pregnant women
(2)
Travellers
(1)
Publication date
2022
(4)
2021
(4)
2020
(15)
2019
(2)
2012
(1)
26 results found
2022
∙
Xu, B. Zhu, Y.
A systematic review and meta-analysis of the factors associating the willingness of Chinese community residents to receive COVID-19 vaccine
2022
∙
Bai, X. Chen, L. Liu, X. Tong, Y. Wang, L. Zhou, M. Li, Y. Hu, G.
Adult Hepatitis B Virus Vaccination Coverage in China from 2011 to 2021: A Systematic Review
2022
∙
Chen, Z. Peng, Y. Wu, X. Pang, B. Yang, F. Zheng, W. Liu, C. Zhang, J.
Comorbidities and complications of COVID-19 associated with disease severity, progression, and mortality in China with centralized isolation and hospitalization: A systematic review and meta-analysis
2022
∙
Fu, Y. Zhao, J. Wei, X. Han, P. Yang, L. Ren, T. Zhan, S. Li, L.
Effectiveness and Cost-Effectiveness of Inactivated Vaccine to Address COVID-19 Pandemic in China: Evidence From Randomized Control Trials and Real-World Studies
2021
∙
Cheng, S. Zhao, Y. Wang, F. Chen, Y. Kaminga, A. C. Xu, H.
Comorbidities' potential impacts on severe and non-severe patients with COVID-19: A systematic review and meta-analysis
2021
∙
Hoang, T. Anh, T. T. T.
Comparison of comorbidities in relation to critical conditions among coronavirus disease 2019 patients: A network meta-analysis
2021
∙
Yin, T. Li, Y. Ying, Y. Luo, Z.
Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors
2021
∙
ATAGI
ATAGI statement on AstraZeneca vaccine in response to new vaccine safety concerns - 8 April, 2021
2020
∙
Parveen, R. Sehar, N. Bajpai, R. Bharal Agarwal, N.
Association of diabetes and hypertension with disease severity in covid-19 patients: a systematic literature review and exploratory meta-analysis
2020
∙
Zhang, J. Wu, J. Sun, X. Xue, H. Shao, J. Cai, W. Jing, Y. Yue, M. Dong, C.
Associations of hypertension with the severity and fatality of SARS-CoV-2 infection: A meta-analysis
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register